EUVIMEDEUVIMED entdecken
Crossref

Immunotherapy plus stereotactic radiation therapy improves event‐free survival in early‐stage non–small cell lung cancer

Cancer · 2023

DOI: 10.1002/cncr.35088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, 2023. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Radiosurgery, Small Cell Lung Carcinoma. Die Arbeit nennt 1 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsRadiosurgerySmall Cell Lung CarcinomaHumansProgression-Free SurvivalImmunotherapyTreatment OutcomeNeoplasm Staging

Zitieren

APA

(2023). Immunotherapy plus stereotactic radiation therapy improves event‐free survival in early‐stage non–small cell lung cancer. Cancer. https://doi.org/10.1002/cncr.35088

Vancouver

Immunotherapy plus stereotactic radiation therapy improves event‐free survival in early‐stage non–small cell lung cancer. Cancer. 2023. doi:10.1002/cncr.35088

BibTeX
@article{euvimed2023,
  title = {Immunotherapy plus stereotactic radiation therapy improves event‐free survival in early‐stage non–small cell lung cancer},
  journal = {Cancer},
  year = {2023},
  doi = {10.1002/cncr.35088}
}
Kostenlos starten →